Regenerative Medicines Market

Regenerative Medicine Market (Bone and Joint) (Technology - Stem Cell Therapy, Biomaterial and Tissue Engineering; Application - Bone Graft Substitutes, Osteoarticular Diseases, Allogeneic Products, Autogenic Products and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019

  • Rep Id : TMRGL419
  • Published On : Jul 2014
  • No. of Pages : 85
  • Category : Healthcare

 

Chapter 1 Introduction

1.1 Report Description

1.2 Market Segmentation

1.3 Research Methodology

      1.3.1 Assumptions

1.4 List of Abbreviations

 

Chapter 2 Executive Summary

2.1 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

2.2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

2.3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 and 2019 (Value %)

 

Chapter 3 Market Overview

3.1 Overview

3.2 Market Drivers

      3.2.1 Technological innovations in biomaterials, stem cell therapy and tissue engineering are fueling the development of regenerative medicine products

      3.2.2 Growing prevalence of bone and joint disorders demand the growth of regenerative medicine products

      3.2.3 Growing number of orthopedic surgeries fuels the growth of the global regenerative medicine (bone and joint) market

3.3 Restraints

      3.3.1 Regulatory constraints pose a threat to the development of regenerative medicine (bone and joint) market

      3.3.2 Ethical issues and post implantation infections are hindering overall market growth

3.4 Opportunities

      3.4.1 Capitalization on the potential presented by emerging markets in Asia Pacific

3.5 Porter’s Five Force Analysis: Global Regenerative Medicine (Bone and Joint) Market

      3.5.1 Bargaining power of suppliers

      3.5.2 Bargaining power of buyers

      3.5.3 Threat of new entrants

      3.5.4 Threat of substitutes

      3.5.5 Competitive rivalry

3.6 Competitive Landscape

      3.6.1 Market Share Analysis by Key Players, 2012 (Value %)

3.7 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography

 

Chapter 4 Regenerative Medicine (Bone and Joint) Market, by Technology

4.1 Introduction

      4.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

4.2 Stem Cell Therapy

      4.2.1 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

4.3 Biomaterials

      4.3.1 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

4.4 Tissue Engineering

      4.4.1 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 5 Regenerative Medicine (Bone and Joint) Market, by Applications

5.1 Overview

      5.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

5.2 Bone Graft Substitutes

      5.2.1 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

5.3 Osteoarticular Diseases

      5.3.1 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

5.4 Allogeneic Bones

      5.4.1 Global Allogenic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

5.5 Autogenic Bones

      5.5.1 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

5.6 Others

      5.6.1 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 6 Regenerative Medicine (Bone and Joint) Market, by Geography

6.1 Overview

      6.1.1 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

6.2 North America

      6.2.1 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.3 Europe

      6.3.1 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.4 Asia-Pacific

      6.4.1 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

6.5 Rest of the World (RoW) 

      6.5.1 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

 

Chapter 7 Recommendations

7.1 Market Strategy for Success

      7.1.1 Rigorous research and development initiatives for innovative products

      7.1.2 Investing in emerging economies

7.2 Barriers and Future Assumptions

      7.2.1 Ethical issues pertaining to stem cell therapy hampering market growth

 

Chapter 8 Company Profiles

8.1 Anika Therapeutics, Inc. 

      8.1.1 Company Overview

      8.1.2 Financial Overview

      8.1.3 Product Portfolio

      8.1.4 Business Strategies

      8.1.5 Recent Developments

8.2 Arthrex, Inc. 

      8.2.1 Company Overview

      8.2.2 Financial Overview

      8.2.3 Product Portfolio

      8.2.4 Business Strategies

      8.2.5 Recent Developments

8.3 Baxter International, Inc. 

      8.3.1 Company Overview

      8.3.2 Financial Overview

      8.3.3 Product Portfolio

      8.3.4 Business Strategies

      8.3.5 Recent Developments

8.4 CONMED Corporation

      8.4.1 Company Overview

      8.4.2 Financial Overview

      8.4.3 Product Portfolio

      8.4.4 Business Strategies

      8.4.5 Recent Developments

8.5 DePuy Synthes, Inc. 

      8.5.1 Company Overview

      8.5.2 Financial Overview

      8.5.3 Product Portfolio

      8.5.4 Business Strategies

      8.5.5 Recent Developments

8.6 Medtronic, Inc. 

      8.6.1 Company Overview

      8.6.2 Financial Overview

      8.6.3 Product Portfolio

      8.6.4 Business Strategies

      8.6.5 Recent Developments

8.7 Smith & Nephew plc

      8.7.1 Company Overview

      8.7.2 Financial Overview

      8.7.3 Product Portfolio

      8.7.4 Business Strategies

      8.7.5 Recent Developments

8.8 Stryker Corporation

      8.8.1 Company Overview

      8.8.2 Financial Overview

      8.8.3 Product Portfolio

      8.8.4 Business Strategies

      8.8.5 Recent Developments

8.9 Zimmer Holdings, Inc. 

      8.9.1 Business Overview

      8.9.2 Financial Overview

      8.9.3 Product Portfolio

      8.9.4 Business Strategies

      8.9.5 Recent Developments

List of Tables

 

TABLE 1 List of Abbreviations

TABLE 2 Market Snapshot: Global Regenerative Medicine (Bone and Joint) Market (2012 & 2019) 

TABLE 3 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Technology, 2011 – 2019 (USD Million) 

TABLE 4 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Applications, 2011 – 2019 (USD Million) 

TABLE 5 Global Regenerative Medicine (Bone and Joint) Market Revenue, by Geography, 2011 – 2019 (USD Million) 

List of Figures

 

FIG. 1 Regenerative Medicine (Bone and Joint): Market Segmentation

FIG. 2 Global Regenerative Medicine (Bone and Joint) Market, by Technology, 2012 (USD Million) 

FIG. 3 Comparative Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 & 2019 (Value %)

FIG. 4 Porter’s Five Forces Analysis: Global Regenerative Medicine (Bone and Joint) Market

FIG. 5 Market Share Analysis: Regenerative Medicine (Bone and Joint) Market, 2012 (Value %)

FIG. 6 Market Attractiveness Analysis: Global Regenerative Medicine (Bone and Joint) Market, by Geography, 2012 Value (%)

FIG. 7 Global Stem Cell Therapy Market Revenue, 2011 – 2019 (USD Million) 

FIG. 8 Global Biomaterials Market Revenue, 2011 – 2019 (USD Million) 

FIG. 9 Global Tissue Engineering Market Revenue, 2011 – 2019 (USD Million) 

FIG. 10 Global Bone Graft Substitute Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 11 Global Osteoarticular Diseases Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 12 Global Allogeneic Bones Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 13 Global Autogenic Bone Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 14 Global Others Application Market Revenue, 2011 – 2019 (USD Million) 

FIG. 15 North America Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 16 Europe Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 17 Asia-Pacific Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 18 RoW Regenerative Medicine (Bone and Joint) Market Revenue, 2011 – 2019 (USD Million) 

FIG. 19 Anika Therapeutics, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 20 Baxter International, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 21 Conmed Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 22 Johnson & Johnson, Orthopedic Franchise**, Annual Revenue: 2011 – 2013 (USD Million) 

FIG. 23 Medtronic, Inc.: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 24 Smith & Nephew PLC: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 25 Stryker Corporation: Annual Revenue, 2011 – 2013 (USD Million) 

FIG. 26 Zimmer Holdings. Inc,: Annual Revenue, 2011 – 2013 (USD Million) 

.